US Physicalrapy Valuation
| USPH Stock | USD 96.94 2.88 3.06% |
At this time, the company appears to be undervalued. US Physicalrapy owns a latest Real Value of $112.45 per share. The recent price of the company is $96.94. Our model measures the value of US Physicalrapy from analyzing the company fundamentals such as Profit Margin of 0.04 %, return on equity of 0.0475, and Current Valuation of 1.56 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting US Physicalrapy's valuation include:
Price Book 2.9411 | Enterprise Value 1.6 B | Enterprise Value Ebitda 23.2151 | Price Sales 2.2898 | Forward PE 37.3134 |
Undervalued
Today
Please note that US Physicalrapy's price fluctuation is very steady at this time. Calculation of the real value of US Physicalrapy is based on 3 months time horizon. Increasing US Physicalrapy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since US Physicalrapy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of USPH Stock. However, US Physicalrapy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 96.94 | Real 112.45 | Target 124.75 | Hype 96.94 | Naive 94.62 |
The intrinsic value of US Physicalrapy's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence US Physicalrapy's stock price.
Estimating the potential upside or downside of US Physicalrapy helps investors to forecast how USPH stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of US Physicalrapy more accurately as focusing exclusively on US Physicalrapy's fundamentals will not take into account other important factors: When choosing an evaluation method for US Physicalrapy, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
US Physicalrapy Cash |
|
USPH Valuation Trend
US Physicalrapy's real value analysis enables investors to forecast the earnings more efficiently. Using both US Physicalrapy's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
USPH Revenue by Product
US Physicalrapy Total Value Analysis
US Physicalrapy is at this time projected to have valuation of 1.56 B with market capitalization of 1.46 B, debt of 258.59 M, and cash on hands of 48.57 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the US Physicalrapy fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.56 B | 1.46 B | 258.59 M | 48.57 M |
US Physicalrapy Investor Information
About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 32.02. The company last dividend was issued on the 15th of November 2024. US Physicalrapy had 3:2 split on the 29th of June 2001. Based on the key measurements obtained from US Physicalrapy's financial statements, US Physicalrapy is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.US Physicalrapy Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. US Physicalrapy has an asset utilization ratio of 60.65 percent. This signifies that the Company is making $0.61 for each dollar of assets. An increasing asset utilization means that US Physicalrapy is more efficient with each dollar of assets it utilizes for everyday operations.US Physicalrapy Ownership Allocation
The majority of US Physicalrapy outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in US Physicalrapy to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in US Physicalrapy. Please pay attention to any change in the institutional holdings of US Physicalrapy as this could imply that something significant has changed or is about to change at the company. On November 7, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of US Physicalrapy's common stock.US Physicalrapy Profitability Analysis
The company reported the previous year's revenue of 604.8 M. Net Income was 37.22 M with profit before overhead, payroll, taxes, and interest of 112.02 M.US Physicalrapy Past Distributions to stockholders
About US Physicalrapy Valuation
An absolute valuation paradigm, as applied to USPH Stock, attempts to find the value of US Physicalrapy based on its fundamental and basic technical indicators. By analyzing US Physicalrapy's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of US Physicalrapy's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of US Physicalrapy. We calculate exposure to US Physicalrapy's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of US Physicalrapy's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 112 M | 117.6 M | |
| Pretax Profit Margin | 0.08 | 0.09 | |
| Operating Profit Margin | 0.12 | 0.07 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.19 | 0.29 |
A single share of US Physicalrapy represents a small ownership stake in the entity. As a stockholder of USPH, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
US Physicalrapy Dividends Analysis For Valuation
As of now, US Physicalrapy's Dividends Paid is increasing as compared to previous years. The US Physicalrapy's current Dividend Yield is estimated to increase to 0.02, while Dividend Paid And Capex Coverage Ratio is projected to decrease to 2.38. . As of now, US Physicalrapy's Retained Earnings are increasing as compared to previous years. The US Physicalrapy's current Price Earnings Ratio is estimated to increase to 94.56, while Retained Earnings Total Equity is projected to decrease to under 158.3 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 24.1 M | 25.3 M | |
| Dividend Yield | 0.02 | 0.02 | |
| Dividend Payout Ratio | 1.64 | 1.73 | |
| Dividend Paid And Capex Coverage Ratio | 2.45 | 2.38 |
There are various types of dividends US Physicalrapy can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of USPH shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from US Physicalrapy directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When USPH pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of US Physicalrapy by the value of the dividends paid out.
US Physicalrapy Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.2 M | |
| Quarterly Earnings Growth Y O Y | -0.238 | |
| Forward Price Earnings | 37.3134 |
US Physicalrapy Current Valuation Indicators
Valuation refers to the process of determining the present value of US Physicalrapy and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value USPH we look at many different elements of the entity such as USPH's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as US Physicalrapy, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use US Physicalrapy's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes US Physicalrapy's worth.Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |